FounderDeckPack

Journal of Nuclear Medicine

80
Signal
JM

Journal of Nuclear Medicine

jnm.snmjournals.org
Creator Toolsjnm.snmjournals.org

The best medical journal covering nuclear medicine and molecular imaging

FounderDeck estimate
$650k
Valued 2026-09-23
Trending Now 0 portfolios
View Journal of Nuclear Medicine company profile

Journal of Nuclear Medicine

The best medical journal covering nuclear medicine and molecular imaging

jnm.snmjournals.org

Is this your company?

Claim it to edit details, or request removal anytime.

Trending NowUnclaimed ProfileShareableVenture-Scale SignalFeatured
FounderDeck estimate
$650k
Medium confidenceValued Sep 23, 2026
0
Portfolios
Browse companies freely. New portfolio additions come exclusively from your daily pack.
B2B SaaSLive product
0
Momentum
0
Daily views
0
Pack saves

Momentum rises when people search, view, like, share, claim, or save this profile.

What it does

The best medical journal covering nuclear medicine and molecular imaging FounderDeck captured this company from its public website and generated an early discovery profile from the product signals visible on the page.

Who it helps

Likely aimed at creators, marketers, or media teams trying to produce, edit, publish, or grow faster.

Why it's interesting

Journal of Nuclear Medicine shows a live product footprint, a visible market angle, and enough public signal to be worth tracking early on FounderDeck.

Profile signals

Signal Score80
Product Clarity89
Founder Momentum72
Market Potential81
Website Polish92
Monetisation69
Shareability89
Buzz96

AI-assisted scores estimated from public website information only.

FounderDeck estimate

Medium confidence
$650k

FounderDeck estimated this early value from the public website, product clarity, market shape, monetisation cues, and overall signal strength visible on the page.

Valuation date: 2026-09-23. Estimate generated from public signals.

Portfolio saves

Added to 0 portfolios.

Portfolio saves do not represent ownership, equity, investment rights, IP rights, or affiliation.

Estimates are AI-generated from public information and are not financial advice or verified company valuations.